Acrivon TherapeuticsACRV
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 53 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, down 10 from Q1 2025. 15 opened new positions and 25 sold out. The largest holders were Ra Capital Management, L.P. ($9.9M), Sands Capital Alternatives, LLC ($2.5M) and Citadel Advisors ($2.3M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $2.0M |
| Exits | 25 | $11.4M |
All 13F filers, Q1 2025 → Q2 2025: 2,328,195 shares bought and 7,056,886 shares sold, net −4,728,691 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 53 holders
| Ra Capital Management, L.P. | 0.17% | No change | 8,340,508 | $9.9M |
| Sands Capital Alternatives, LLC | 0.50% | No change | 2,122,605 | $2.5M |
| Citadel Advisors | 0.00% | No change | 1,895,519 | $2.3M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $1.1M |
| Vanguard Group Inc. | 0.00% | Reduce -12.1% | 593,247 | $706K |
| Renaissance Technologies | 0.00% | Add +877.5% | 509,295 | $606K |
| BlackRock, Inc. | 0.00% | Reduce -56.6% | 407,622 | $485K |
| Acorn Capital Advisors, LLC | 0.32% | No change | 405,237 | $482K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 382,234 | $455K |
| Jane Street Group, LLC | 0.00% | New | 311,829 | $371K |
| Millennium Management | 0.00% | New | 296,239 | $353K |
| Marshall Wace, LLP | 0.00% | Reduce -59.8% | 181,187 | $216K |
| Two Sigma Investments, LP | 0.00% | New | 181,172 | $216K |
| Geode Capital Management, LLC | 0.00% | Reduce -46.3% | 164,362 | $196K |
| Squarepoint Ops LLC | 0.00% | New | 152,605 | $182K |
| HRT Financial LP | 0.00% | New | 145,895 | $173K |
| Goldman Sachs Group Inc. | 0.00% | Add +143.5% | 140,055 | $167K |
| XTX Topco Ltd | 0.01% | New | 106,119 | $126K |
| State Street Corp. | 0.00% | Reduce -71.1% | 67,145 | $80K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -42.8% | 63,636 | $76K |
| Morgan Stanley | 0.00% | Add +78.9% | 63,016 | $75K |
| Northern Trust Corp. | 0.00% | Reduce -57.1% | 46,776 | $56K |
| Susquehanna International Group, LLP | 0.00% | Add +200.8% | 43,860 | $52K |
| Two Sigma Advisers, LP | 0.00% | New | 32,600 | $39K |
| Citigroup Inc. | 0.00% | Add +190.2% | 32,382 | $39K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -70.6% | 22,900 | $27K |
| Baker Bros. Advisors LP | 0.00% | No change | 22,809 | $27K |
| AQR Capital Management | 0.00% | New | 22,252 | $26K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -49.7% | 22,204 | $26K |
| Quadrature Capital Ltd | 0.00% | New | 22,175 | $26K |
| Barclays PLC | 0.00% | Reduce -36.0% | 20,925 | $25K |
| Bank of America Corp. | 0.00% | Reduce -25.6% | 20,617 | $25K |
| SG Americas Securities, LLC | 0.00% | New | 15,265 | $18K |
| Qube Research & Technologies Ltd | 0.00% | New | 12,692 | $15K |
| Ground Swell Capital, LLC | 0.02% | New | 12,215 | $15K |
| FMR LLC | 0.00% | Add +269.6% | 9,850 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +186.2% | 8,844 | $11K |
| China Universal Asset Management Co., Ltd. | 0.00% | Add +0.8% | 6,298 | $7K |
| Federated Hermes, Inc. | 0.00% | New | 2,318 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -83.3% | 1,418 | $2K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +16.2% | 1,211 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -25.8% | 992 | $1K |
| Cwm, LLC | 0.00% | Add +1512.2% | 790 | $1K |
| GF Fund Management Co. LTD. | 0.00% | No change | 772 | $919 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -39.1% | 584 | $695 |
| Redwood Park Advisors LLC | 0.00% | No change | 500 | $595 |
| Russell Investments Group, Ltd. | 0.00% | New | 481 | $572 |
| UBS Group AG | 0.00% | Reduce -96.5% | 455 | $541 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $476 |
| True Wealth Design, LLC | 0.00% | Add +5766.7% | 176 | $210 |
| Wells Fargo & Company | 0.00% | Reduce -98.0% | 141 | $168 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $88 |
| Royal Bank of Canada | 0.00% | Reduce -96.3% | 31 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.